Foreign companies entering the Philippine market with regulated products must satisfy both business and product-specific requirements. Depending on the product, this may include establishing a Philippine entity, securing a Food and Drug Administration (FDA) License to Operate (LTO), and obtaining the appropriate product authorization.
One option available to businesses during this process is CPR Housing. This is a commercial arrangement in which an existing Philippine FDA-licensed establishment or regulatory partner supports the product registration process while the foreign company establishes its own local business and regulatory structure.
CPR Housing can help businesses coordinate these requirements more efficiently, but it does not replace Philippine company registration or FDA compliance.
CPR Housing refers to a service arrangement that allows a qualifying business to use an existing FDA-licensed local establishment or regulatory representative for purposes connected with product registration.
The term itself is not an FDA-issued license or certification.
The relevant government authorization is the Certificate of Product Registration (CPR), which applies to regulated products that require FDA market authorization. The FDA also issues other authorizations, including Licenses to Operate and Certificates of Product Notification, depending on the establishment and product involved.
This distinction is important because not every FDA-regulated product follows the same registration process.
CPR Housing can be useful for foreign companies that want to prepare their Philippine product registration while developing their permanent local structure.
Without an appropriate local regulatory arrangement, a company may have to complete multiple stages of market entry before it can proceed with product registration. CPR Housing can help coordinate the regulatory work during this transition, where permitted under applicable FDA requirements.
This can be particularly relevant to companies that:
The arrangement should be structured according to the specific product and FDA requirements rather than treated as a universal solution.
Understanding the difference between a CPR and an LTO is essential when planning FDA compliance.
A License to Operate (LTO) applies to the establishment and authorizes covered activities under the FDA’s regulatory framework.
A Certificate of Product Registration (CPR) applies to the particular regulated product.
In simple terms:
LTO = establishment authorization
CPR = product market authorization
A business may therefore need both, depending on its activities and product.
The FDA’s eServices platform provides separate application processes for establishment licensing and product registration.
CPR Housing is intended to address the local regulatory structure associated with product registration; it does not automatically provide the client’s company with its own Philippine LTO.
The applicable FDA authorization depends on how the product is classified.
Regulated categories can include:
Not every product in these broad categories necessarily requires a CPR. Some products are subject to notification or other authorization procedures.
For example, the FDA maintains separate procedures for food product registration and pharmaceutical product registration, while medical devices are governed by their own regulatory requirements.
Businesses should therefore determine the product classification before deciding whether CPR Housing or a particular FDA registration pathway is appropriate.
The process varies according to the product, but businesses can generally expect several stages.
The first step is to identify the product and determine the applicable FDA category.
Businesses should review the product’s:
Correct classification is important because it determines the applicable FDA requirements.
If the company does not yet have its own Philippine FDA-licensed establishment, it can explore whether a CPR Housing arrangement is appropriate.
The parties should clearly establish who will act as the relevant local regulatory party, who will communicate with the FDA, and who will be responsible for maintaining the product’s regulatory documentation.
Product registration can require substantial technical and administrative documentation.
Depending on the product, this may include:
All information should be consistent across the application and supporting documents.
Applications are submitted through the applicable FDA process or electronic platform.
The FDA reviews the application against the requirements applicable to the product. Processing times vary depending on the product category, application type, completeness of documents, and applicable FDA procedures.
CPR Housing does not guarantee approval.
For businesses intending to operate permanently in the Philippines, CPR Housing should generally be viewed as part of a broader market-entry plan.
The company may eventually need to establish its own Philippine entity and secure the appropriate FDA LTO.
This may involve coordinating:
The exact requirements depend on the company’s intended activities.
Businesses considering CPR Housing should plan for the eventual transition from the beginning.
The company should determine who will hold the relevant product authorization, what entity will operate in the Philippines, and what FDA procedures may be required when the regulatory arrangement changes.
A CPR should not be assumed to transfer automatically from one business to another. Changes involving ownership, responsible entities, business information, or other registration details may require formal FDA procedures and supporting documentation.
Planning this early can help avoid unnecessary disruption when the Philippine company becomes operational.
Businesses can avoid many problems by addressing a few issues early.
It is not. CPR Housing is a private service arrangement. The actual regulatory authorization is the applicable FDA registration or license.
FDA requirements vary by product. Some products may require notification or another form of authorization instead.
CPR Housing should not be treated as a replacement for establishing a proper Philippine business structure when the company intends to operate locally.
FDA regulations and procedures can change. Businesses should verify the current requirements applicable to their specific product before filing.
A consultant or regulatory representative can prepare and coordinate an application, but the FDA makes the final regulatory determination.
For foreign businesses, CPR Housing can form part of a coordinated market-entry strategy.
A typical structure may involve:
Business registration → FDA establishment licensing → Product registration → Importation/distribution → Ongoing compliance
Where appropriate, CPR Housing can help businesses manage the product-registration component while their permanent Philippine structure is being established.
The objective should be more than obtaining a product certificate. Businesses should develop a regulatory structure that supports lawful market entry and continued operations in the Philippines.
Before entering into a CPR Housing arrangement, businesses should have a clear understanding of the following.
Product
Manufacturer
Philippine Market Entry
Regulatory Transition
Ongoing Compliance
Answering these questions before starting the application gives the business a clearer regulatory roadmap.
CPR Housing can be a useful market-entry arrangement for foreign companies and new Philippine businesses that need to coordinate FDA product registration with the establishment of their own local operations.
The most important points are straightforward:
For a foreign business, the objective should not simply be obtaining a CPR as quickly as possible. The broader objective is to establish a regulatory structure that allows the company to introduce its products into the Philippines lawfully and maintain compliance as it grows.
Yes. Business Registration Philippines assists foreign companies with establishing and structuring their Philippine operations, including coordinating business registration and relevant regulatory requirements.
If your company plans to introduce an FDA-regulated product into the Philippines, we can help you understand the relationship between company registration, FDA licensing, CPR Housing, and product registration and identify the appropriate next steps for your business.